AVNS

Avanos Medical Inc. (AVNS) | Rumor.io

Avanos Medical

AVNS

Attention (50-day avg)0%

Attention rank (50-day avg)#3,745

Bullish sentiment (50-day avg)100%

Price to earnings ratio34.4

Market capitalization1.2B

Earnings per share-1.6

Dividend yield (TTM)—

Revenue (annual)701.2M

Net income (annual)-72.9M

Social

What share of all stock conversation is about AVNS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Apr 15

Avanos Medical, Inc. ($AVNS) is being acquired by American Industrial Partners in an all-cash deal valued at $1.27B, a significant premium that validates the company's strategic position.
The acquisition is expected to be completed in H2 2026, pending majority shareholder vote and HSR antitrust approval.
The deal is a textbook M&A exit play, with private equity seeing major value in the company's growth prospects, as CEO Dave Pacitti has stated that AIP will back Avanos' growth.

Generated by AI

Sentiment

Of the messages about AVNS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	93.67% +53.67
Bearish	—	—	—	6.33% -53.67

Apr 14

$AVNS surges 69.51% to $24.63 on acquisition news, with a $1.27B all-cash deal providing a fundamental catalyst.
The company decisively breaches key resistance at $18.39, with massive volume confirming institutional participation and a target of $40.94.
$AVNS breaks $18.41 resistance, with a price of $24.68 and a 69.82% increase, driven by deal news and a technical target of $41.10.

Generated by AI

Topics

Of the messages about AVNS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	90.2%
Analysts	—	—	0%	0%
Controversies	—	—	0%	0.41%
Earnings	—	—	0%	6.53%
Macro	—	—	0%	0.41%
Technical Analysis	—	—	0%	2.45%

Earnings· Nov 5

Avanos Medical ($AVNS) reported Q3 earnings of $0.30 EPS and $171.40M revenue, missing estimates by $0.01 and $8.58M, respectively.
The company guided FY19 EPS below consensus and revenue below consensus.
Avanos Medical's shares declined 20% following the Q3 miss and guidance cut, with the stock showing its highest volume in at least two quarters.

Announcements· Apr 14

Avanos Medical, Inc. ($AVNS) agrees to be acquired by American Industrial Partners for approximately $1.272 billion in enterprise value, delivering immediate and compelling value to shareholders.
Avanos stockholders will receive $25 per share in cash for each share of common stock they own, representing a premium of 72.06% from the stock’s last close.
The deal is expected to close in the second half of 2026, positioning the company for continued growth and removing all regulatory uncertainty.

Technical Analysis· Apr 14

$AVNS breaks through key resistance at $18.41, confirming a powerful breakout momentum with a +69.86% surge.
The private acquisition news provides a fundamental catalyst, aligning the technical target at $41.10.
The move is characterized by strong momentum, high volume, and a trend confirmation, with the key now being whether price holds above breakout levels and buyers defend dips.

Generated by AI

Community

Of the messages about AVNS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	6.25%
Newcomers	—	—	0%	93.75%

Regulars· May 3

Avanos Medical's Q1 2023 earnings report was released, with the company missing expectations by $0.01 in EPS and $3.5M in revenue.
The company has updated its FY 2023 earnings guidance, and its Q1 2023 earnings report is available in the 10-Q filing.
Avanos Medical's Q1 2023 EPS of $0.27 and revenue of $191.7M both missed expectations, with the company's fundamentals being called into question by some analysts.

Newcomers· Apr 15

The acquisition of Avanos Medical Inc. by American Industrial Partners for $1.27B in cash is a significant premium that validates the company's strategic position.
The buyout is expected to deliver a massive return on investment, making it a high-risk opportunity for traders.
The technical breakout of Avanos Medical Inc. is fueled by the acquisition, with the stock price surging to $24.63 and a target price of $4097.16.

Generated by AI

News

Avanos Medical Acquired by AIP and Taken Private

Detailed price information for Avanos Medical Inc (AVNS-N) from The Globe and Mail including charting and trades.

2mo agoThe Globe and Mail

Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition

NEW YORK, July 29, 2026--Sterlington advises Avanos Medical management team on $1.27 billion acquisition.

2mo agoYahoo Finance

American Industrial Partners completes Avanos Medical acquisition

2mo agoInvesting.com

Also Discussed

Investors talking about AVNS also mention

#	Name	Attention
1	MKDWELL Tech Inc.MKDW	0%+0
2	LanzaTech Global Inc. Common StockLNZA	0%new
3	Baird Medical Investment Holdings Ltd.BDMD	0%new
4	Distribution Solutions Group, Inc.DSGR	0%0
5	Roma Green Finance LimitedROMA	0%0
6	Zentalis Pharmaceuticals, Inc.ZNTL	0%new
7	PTL Limited Class A Ordinary SharesPTLE	0%new
8	Luda Technology Group Ltd.LUD	0%0
9	Falcon's Beyond Global, Inc. Class A Common StockFBYD	0%new
10	OneConstruction Group Ltd.ONEG	0%0

Avanos Medical Inc.

Healthcare
Medical Devices

Avanos Medical Inc. is a healthcare company specializing in the development and production of medical devices designed to improve patient outcomes and reduce procedural costs. Primarily focusing on chronic care and pain management solutions, Avanos Medical offers a diverse range of products, including enteral feeding systems, respiratory therapy equipment, and advanced pain management technologies. The company's products are utilized in various healthcare settings such as hospitals, home care environments, and outpatient facilities. With its commitment to innovative healthcare solutions, Avanos Medical plays a crucial role in enhancing patient care quality and operational efficiency in the medical sector. By continually evolving its product offerings, Avanos seeks to address the growing demands and challenges faced by healthcare providers worldwide.

Website

Location

5405 Windward Parkway

Alpharetta, GA, 30004

United States

Social

What share of all stock conversation is about AVNS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Apr 15

Avanos Medical, Inc. ($AVNS) is being acquired by American Industrial Partners in an all-cash deal valued at $1.27B, a significant premium that validates the company's strategic position.
The acquisition is expected to be completed in H2 2026, pending majority shareholder vote and HSR antitrust approval.
The deal is a textbook M&A exit play, with private equity seeing major value in the company's growth prospects, as CEO Dave Pacitti has stated that AIP will back Avanos' growth.

Generated by AI

Sentiment

Of the messages about AVNS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	93.67% +53.67
Bearish	—	—	—	6.33% -53.67

Apr 14

$AVNS surges 69.51% to $24.63 on acquisition news, with a $1.27B all-cash deal providing a fundamental catalyst.
The company decisively breaches key resistance at $18.39, with massive volume confirming institutional participation and a target of $40.94.
$AVNS breaks $18.41 resistance, with a price of $24.68 and a 69.82% increase, driven by deal news and a technical target of $41.10.

Generated by AI

Topics

Of the messages about AVNS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	90.2%
Analysts	—	—	0%	0%
Controversies	—	—	0%	0.41%
Earnings	—	—	0%	6.53%
Macro	—	—	0%	0.41%
Technical Analysis	—	—	0%	2.45%

Earnings· Nov 5

Avanos Medical ($AVNS) reported Q3 earnings of $0.30 EPS and $171.40M revenue, missing estimates by $0.01 and $8.58M, respectively.
The company guided FY19 EPS below consensus and revenue below consensus.
Avanos Medical's shares declined 20% following the Q3 miss and guidance cut, with the stock showing its highest volume in at least two quarters.

Announcements· Apr 14

Avanos Medical, Inc. ($AVNS) agrees to be acquired by American Industrial Partners for approximately $1.272 billion in enterprise value, delivering immediate and compelling value to shareholders.
Avanos stockholders will receive $25 per share in cash for each share of common stock they own, representing a premium of 72.06% from the stock’s last close.
The deal is expected to close in the second half of 2026, positioning the company for continued growth and removing all regulatory uncertainty.

Technical Analysis· Apr 14

$AVNS breaks through key resistance at $18.41, confirming a powerful breakout momentum with a +69.86% surge.
The private acquisition news provides a fundamental catalyst, aligning the technical target at $41.10.
The move is characterized by strong momentum, high volume, and a trend confirmation, with the key now being whether price holds above breakout levels and buyers defend dips.

Generated by AI

Community

Of the messages about AVNS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	6.25%
Newcomers	—	—	0%	93.75%

Regulars· May 3

Avanos Medical's Q1 2023 earnings report was released, with the company missing expectations by $0.01 in EPS and $3.5M in revenue.
The company has updated its FY 2023 earnings guidance, and its Q1 2023 earnings report is available in the 10-Q filing.
Avanos Medical's Q1 2023 EPS of $0.27 and revenue of $191.7M both missed expectations, with the company's fundamentals being called into question by some analysts.

Newcomers· Apr 15

The acquisition of Avanos Medical Inc. by American Industrial Partners for $1.27B in cash is a significant premium that validates the company's strategic position.
The buyout is expected to deliver a massive return on investment, making it a high-risk opportunity for traders.
The technical breakout of Avanos Medical Inc. is fueled by the acquisition, with the stock price surging to $24.63 and a target price of $4097.16.

Generated by AI

Avanos Medical

Social

Apr 15

Apr 14

Earnings· Nov 5

Announcements· Apr 14

Technical Analysis· Apr 14

Regulars· May 3

Newcomers· Apr 15

Avanos Medical Acquired by AIP and Taken Private

Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition

American Industrial Partners completes Avanos Medical acquisition

Also Discussed

Avanos Medical Inc.

Company Information

Location

Avanos Medical Acquired by AIP and Taken Private

Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition

American Industrial Partners completes Avanos Medical acquisition

Also Discussed

Social

Apr 15

Apr 14

Earnings· Nov 5

Announcements· Apr 14

Technical Analysis· Apr 14

Regulars· May 3

Newcomers· Apr 15